ViroCarb is taking a pioneering approach to address the urgent need for effective treatments of existing and emerging infections caused by viruses. By impairing RNA processing, a crucial cellular process essential for the replication of multiple viruses.
Our Mission
To develop and commercialize our small molecule platform of broad spectrum anti-viral drugs to overcome the clinical challenge of current and future viral infections via a single mechanism, rather than the present piecemeal approach to individual viruses.